Vanguard Global Advisers, LLC

Vanguard Global Advisers, LLC — the investment-adviser arm separate from the larger fiduciary trust — entered Q1 2026 with $185 billion deployed in a portfolio whose defining feature is that its top two holdings are not individual stocks at all but Vanguard's own flagship ETFs: VOO (S&P 500) at $23.7 billion (12.8% of the book) and VTI (Total Stock Market) at $11.8 billion (6.4%). Together these two products alone consume nearly a fifth of the entire portfolio, making this entity simultaneously the most interesting and the most self-referential vehicle in this quarter's Vanguard filings. NVIDIA rounds out the top three at $9.3 billion (5.0%), sitting as one of the few individual equity positions in a portfolio otherwise dominated by wrapper products. Healthcare (Johnson & Johnson, Eli Lilly, Merck, AbbVie), Financials (JPMorgan, Bank of America, Wells Fargo, Visa, Goldman Sachs, Canadian banks), and Consumer Staples (Walmart, Costco, Coca-Cola, PepsiCo, McDonald's) fill the traditional ballast — but at secondary weight behind Vanguard's own ETFs. Transaction reporters would do well to read this filing as a structural signal: when Vanguard's largest institutional vehicle is buying its own asset-management products at $35.5 billion in aggregate, that demand is itself a self-reinforcing force on ETF flows and underlying securities liquidity.